Cybin Inc. (CYBN)
AMEX: CYBN
· Real-Time Price · USD
7.08
-0.09 (-1.26%)
At close: Aug 15, 2025, 3:59 PM
7.26
2.61%
After-hours: Aug 15, 2025, 06:43 PM EDT
-1.26% (1D)
| Bid | 7.06 |
| Market Cap | 162.89M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -113.14M |
| EPS (ttm) | -4.47 |
| PE Ratio (ttm) | -1.58 |
| Forward PE | -1.59 |
| Analyst | Buy |
| Ask | 7.46 |
| Volume | 400,013 |
| Avg. Volume (20D) | 394,320 |
| Open | 7.16 |
| Previous Close | 7.17 |
| Day's Range | 6.99 - 7.23 |
| 52-Week Range | 4.81 - 13.88 |
| Beta | 1.12 |
About CYBN
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CYBN
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CYBN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+12.5%
Cybin shares are trading higher after the company ...
Unlock content with
Pro Subscription
1 month ago
+5.8%
Shares of psychedelic companies are trading higher following a report suggesting that the US Department of Health and Human Services Secretary Robert F. Kennedy Jr said the agency is committed to expanding research on the benefits of psychedelic therapy and is working with the FDA head to provide legal access for military veterans within 12 months.
